Silexion Therapeutics Ltd. (SLXN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Silexion Therapeutics Ltd. (SLXN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

SLXN Income Statement

Silexion Therapeutics Ltd. (SLXN) annual income statement — 6-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q1'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	3K	2K	0	4K	0	0	0	22K	7K	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-3K	-2K	0	-4K	0	0	0	-22K	-7K	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	81.82%	100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	3.68M	2.75M	-18.86M	3.29M	2.28M	1.65M	1.9M	8.01M	1.38M	1.25M	1.73M	731K	155.47K	808	488.11K	237K	156.99K	350.24K	433.4K	92.65K
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	1.47M	1.38M	1.03M	1.13M	1.26M	1.06M	1.04M	4.8M	612K	281K	465K	186K	155.47K	127	488.11K	237K	156.99K	350.24K	433.4K	92.65K
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	2.21M	1.37M	3.38M	2.16M	1.02M	590K	871K	3.22M	766K	961K	1.26M	535K	0	681	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	-1000K	0	3K	4K	-12K	22K	0	8K	6K	10K	0	0	0	0	0	0	0	0
Operating Income	-3.68M	-2.75M	18.86M	-3.29M	-2.28M	-1.65M	-1.9M	-8.04M	-1.39M	-1.25M	-1.73M	-731K	-155.47K	-808	-488.11K	-237K	-156.99K	-350.24K	-433.4K	-92.65K
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-61.12%	-66.61%	1092.53%	59.03%	-64.91%	-32%	-9.95%	-999.32%	-790.84%	-	-254.02%	-208.44%	0.97%	99.77%	-12.62%	-	-	-278%	-	-
EBITDA	-3.68M	-2.75M	18.86M	-3.29M	-2.28M	-1.65M	-1.91M	-8.01M	-1.38M	-1.24M	-1.72M	-721K	162.95K	-793	494.41K	292.58K	42.69K	-246K	-242K	-97.75K
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-61.2%	-66.89%	1086.45%	58.97%	-65.53%	-32.53%	-11.03%	-1011.51%	-945.67%	-	-448.29%	-346.43%	281.67%	99.68%	304.3%	-	-	-151.65%	-	-
D&A (Non-Cash Add-back)	3K	2K	3K	4K	3K	4K	-12K	22K	7K	8K	6K	10K	0	15	0	0	0	0	0	0
EBIT	-3.68M	-2.73M	-4.41M	-3.26M	-2.5M	-1.73M	-5.83M	-11.81M	-1.49M	-1.42M	-1.67M	-803K	162.95K	-733	494.41K	292.58K	42.69K	-246K	-242K	-97.75K
Net Interest Income	14K	32K	63K	39K	43K	-9K	0	-52K	4K	19K	33K	227.05K	318K	745.04K	992.92K	520.02K	163.34K	9.39K	2.18K	676
Interest Income	14K	32K	69K	39K	43K	0	0	0	6K	19K	33K	227.05K	318K	745.04K	992.92K	520.02K	163.34K	9.39K	2.18K	676
Interest Expense	0	0	6K	0	0	9K	0	52K	2K	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	129K	16K	-23.27M	30K	-216K	-85K	154K	-3.82M	-102K	-168K	54K	-72K	318.42K	75	982.52K	529.58K	199.69K	104.58K	191.63K	-5.1K
Pretax Income	-3.55M	-2.73M	-4.41M	-3.26M	-2.5M	-1.74M	-1.75M	-11.86M	-1.49M	-1.42M	-1.67M	-803K	162.95K	-733	494.41K	292.58K	42.69K	-245.66K	-241.77K	-97.75K
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	3K	0	1K	2K	2K	5K	6K	6K	0	10	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	-0.12%	0%	-0.06%	-0.02%	-0.13%	-0.35%	-0.36%	-0.75%	0%	-1.36%	0%	0%	0%	0%	0%	0%
Net Income	-3.55M	-2.73M	-4.41M	-3.26M	-2.5M	-1.74M	-1.75M	-11.85M	-1.47M	-1.37M	-1.73M	-787K	162.95K	-774	494.41K	292.58K	42.69K	-246K	-242K	-97.75K
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-41.87%	-57.52%	-152.55%	72.47%	-70.04%	-26.37%	-1.1%	-1405.85%	-1003.36%	-	-449.51%	-368.99%	281.67%	99.69%	304.3%	-	-	-151.65%	-	-
Net Income (Continuing)	-3.55M	-2.73M	-4.41M	-3.26M	-2.5M	-1.74M	-1.75M	-11.86M	-1.49M	-1.42M	-1.68M	-809K	162.95K	-743	494.41K	292.58K	42.69K	-245.66K	-241.77K	-97.75K
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	3.35M	3.37M	3.42M	0	0	0	3.59M	0	0	0	0	0
EPS (Diluted)	-5.17	-8.46	-14.11	-28.80	-43.19	-38.39	-141.75	-2747.21	-1977.97	-1910.48	-17.80	0.13	0.27	0.26	0.33	0.20	0.03	-0.15	-0.15	-0.06
EPS Growth %	88.03%	77.96%	90.05%	98.95%	97.82%	97.99%	-696.35%	-	-	-	-5445.35%	-31.98%	953.85%	274.5%	326.53%	-	-	-152.54%	-	-
EPS (Basic)	-5.17	-8.46	-14.11	-28.80	-43.19	-38.39	-141.75	-2747.21	-1977.97	-1910.48	-17.80	0.13	0.25	0.26	0.30	0.18	0.03	-0.15	-0.15	-0.06
Diluted Shares Outstanding	687.35K	323.04K	312.67K	113.27K	57.95K	45.19K	12.32K	4.32K	744	745	97.12K	552.77K	660.51K	1.21M	1.65M	1.65M	1.65M	1.65M	1.65M	1.65M
Basic Shares Outstanding	687.35K	323.04K	312.67K	113.27K	57.95K	45.19K	12.32K	4.32K	744	745	97.12K	552.77K	660.51K	1.21M	1.65M	1.65M	1.65M	1.65M	1.65M	1.65M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-